Clinical Trial Update: SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C [Phase 2]

View source ↗

Summary

This Phase 2 trial compared the oral thrombopoietin receptor agonist SB497115 to placebo in adults with thrombocytopenia due to chronic hepatitis C and has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Thrombocytopenia

Drugs mentioned

• SB497115

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis C, Chronic, Hepatitis C | Phase 2 | Status: COMPLETED